Skip to content
healthcare.dev

Actemra

NDC 50242-138, tocilizumab, injection, solution, from Genentech, Inc..

Product NDC
50242-138
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125472
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-138 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOCILIZUMAB162 mg/.9mL

Pharmacologic classes

Interleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]

Package NDCNDC-11Package
50242-138-01502420138011 SYRINGE, GLASS in 1 BOX (50242-138-01) / .9 mL in 1 SYRINGE, GLASS
50242-138-86502420138861 SYRINGE, GLASS in 1 BOX (50242-138-86) / .9 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13

Use it

Look up 50242-138 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-138 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-138. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.